Significados de lymphatic mapping em inglês

Results from lymphatic mapping and sentinel node biopsy are highly encouraging.

It is concluded that lymphatic mapping is quickly gaining momentum.

Background: The success of intraoperative lymphatic mapping depends on accurate identification of the sentinel node.

CONCLUSIONS: The use of lymphatic mapping and SLN biopsy effectively stages patients with primary cutaneous melanoma.

Results: Intraoperative lymphatic mapping identified sentinel nodes in 90% of the regional drainage basins.

The method initially reported involved lymphatic mapping by injection of blue dye around the primary melanoma site.

Therefore we initiated a trial to investigate lymphatic mapping for gastric carcinoma at Wake Forest University Baptist Medical Center.

The technique that is best used for lymphatic mapping is well established in melanoma but not in breast cancer.

Twenty-two rats underwent lymphatic mapping in each distal lower extremity with various combinations of carbon dye and isosulfan blue dye.

Patients and methods: In a multi-institutional study, 40 patients with primary CRC underwent dye-directed lymphatic mapping at the time of colon resection.

We believe that lymphatic mapping and sentinel lymph node biopsy will ultimately lead to more conservative treatment of patients with breast cancer.

The operative technique of lymphatic mapping and sentinel node biopsy is described, including the use of a vital dye and a gamma-ray probe.

Methods: Twenty patients with colon cancer underwent lymphatic mapping and sentinel node biopsy using blue dye, fluorescein or lymphoscintigraphy followed by standard surgical resection.

Objective: In the present study, we performed preoperative and intraoperative lymphatic mapping, harvested clinically normal sentinel nodes, and examined them for micrometastasis by light microscopy.

Intraoperative lymphatic mapping using blue dye and a hand-held gamma probe showed the same nodes, as well as a blue node near the vena cava.

At the present time, we believe that lymphatic mapping and selective (sentinel) lymph node dissection is an investigational procedure whose therapeutic utility is unproven.